Rising after prostatectomy. What are my options
Understanding Your Situation
After prostatectomy, your PSA should drop to undetectable levels (typically <0.1 ng/mL). A rising PSA suggests cancer cells may still be present, either:
- Locally (in the prostate bed area)
- Systemically (spread to other areas like lymph nodes or bones)
The Phoenix definition of BCR after surgery is typically PSA rising to ≥0.2 ng/mL on two consecutive measurements.
Key Factors That Guide Treatment Decisions
Your oncologist will consider several important factors:
-
PSA Doubling Time (PSADT) - How quickly your PSA is rising
- Faster doubling times (< 6 months) suggest more aggressive disease
- Slower doubling times may allow for observation or less aggressive approaches
-
Time to BCR - How long after surgery did PSA start rising
- Earlier recurrence (< 2 years) may indicate more aggressive disease
- Later recurrence often has better prognosis
-
Original Gleason Score - Your initial cancer grade
-
Surgical margins - Whether cancer was at the edge of removed tissue
-
Current PSA level - Absolute value matters
Treatment Options to Discuss
Salvage Radiation Therapy
- Radiation to the prostate bed area where the prostate was removed
- According to NCCN Guidelines, this is often recommended when PSA is still relatively low (typically <0.5-1.0 ng/mL)
- More effective when done earlier rather than waiting for higher PSA levels
- May be combined with short-term hormone therapy for better outcomes
Observation/Active Surveillance
- If PSA is rising very slowly with long doubling time
- May be appropriate for older patients or those with other health conditions
- Requires regular PSA monitoring
Hormone Therapy (Androgen Deprivation Therapy - ADT)
- May be added to radiation therapy
- Can be used alone if radiation isn't appropriate
- Various forms available (injections like Lupron/Orgovyx, pills like abiraterone)
Advanced Imaging
Before deciding on treatment, your doctor may recommend:
- PSMA PET/CT scan - Can detect cancer at very low PSA levels (often when PSA >0.2-0.5 ng/mL)
- Helps determine if recurrence is local (treatable with radiation) or systemic (may need different approach)
- According to NCCN Guidelines, PSMA PET imaging is increasingly used to guide treatment decisions in BCR
Critical Questions to Ask Your Oncologist
- What is my PSA doubling time, and what does that suggest about my disease?
- Am I a candidate for salvage radiation therapy? If so, what's the optimal timing?
- Should I get a PSMA PET/CT scan to locate where the cancer might be?
- What are the pros and cons of starting treatment now versus monitoring closely?
- If we do radiation, should it be combined with hormone therapy?
- What are the potential side effects of each treatment option?
Important Context
From the medical literature, about 30% of patients may achieve long-term control with metastasis-directed therapy (like salvage radiation) when cancer is caught early and localized. The key is acting at the right time - not too early when it might not be necessary, but not waiting until PSA is very high.
Your specific situation - including your PSA trend, original pathology, and overall health - will determine the most appropriate approach for YOU.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Prostate Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated November 13, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with general for Prostate Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Prostate Cancer
- What are the treatment options for prostate cancer
- My Prostate Cancer has spread to my brain — what are my options
- Is surgery an option for metastatic Prostate Cancer
- Is proton therapy an option for Prostate Cancer
- What palliative care options are available for Prostate Cancer
- My Prostate Cancer came back — what are my options now
- What respite care options exist for Prostate Cancer caregivers
- There could be a 4th option where the cancer has changed/does not produce PSA